Apixaban-matching placebo

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Deep Vein ThrombosisPulmonary Embolism

Phase 3

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

CompletedNCT00423319

Bristol-Myers SquibbDeep Vein Thrombosis, Pulmonary Embolism

Start: 2007-03-31End: 2009-09-30Updated: 2014-05-14

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

CompletedNCT00452530

Bristol-Myers SquibbDeep Vein Thrombosis, Pulmonary Embolism

Start: 2007-06-30End: 2009-01-31Updated: 2014-07-09

Related Papers

Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.

2022-05-167 citations

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

2010-12-01492 citations

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

2010-03-01517 citations